Kymera readies eczema drug trial results, sees potential Dupixent Investors and doctors are intensely awaiting mid-stage results of an experimental Kymera therapy positioned to rival Dupixent.

Kymera readies eczema drug trial results, sees potential Dupixent Investors and doctors are intensely awaiting mid-stage results of an experimental Kymera therapy positioned to rival Dupixent. Investors and doctors are intensely awaiting mid-stage results of an experimental Kymera therapy positioned to rival Dupixent.